Clinical Effects of Hypomethylating Agents in Patients with Newly Diagnosed Myelodysplastic Syndrome Who Received DNA-Damaging Chemotherapy for Metastatic Breast Cancer

Dong-Won BAEK; Soo-Jung LEE; Sang-Kyun SOHN; Joon-Ho MOON; Yee-Soo CHAE

Clinical Effects of Hypomethylating Agents in Patients with Newly Diagnosed Myelodysplastic Syndrome Who Received DNA-Damaging Chemotherapy for Metastatic Breast Cancer / 한국유방암학회지

Dong-Won BAEK; Soo-Jung LEE; Sang-Kyun SOHN; Joon-Ho MOON; Yee-Soo CHAE.

Journal of Breast Cancer ; : 647-652, 2019.

Article in En | WPRIM | ID: wpr-783956

Responsible library: WPRO

ABSTRACT

ABSTRACT

Subject(s)

Female; Humans; Middle Aged; Azacitidine; Bone Marrow Examination; Breast Neoplasms; Breast; Cyclophosphamide; DNA Methylation; Doxorubicin; Drug Therapy; Hematologic Neoplasms; Lung; Lymph Nodes; Myelodysplastic Syndromes; Neoplasm Metastasis; Paclitaxel; Radiotherapy; Thrombocytopenia

Key words

Azacitidine; Breast neoplasms; DNA methylation; Myelodysplastic syndrome

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Database: WPRIM Main subject: Radiotherapy / Azacitidine / Thrombocytopenia / Bone Marrow Examination / Myelodysplastic Syndromes / Breast / Breast Neoplasms / Doxorubicin / Paclitaxel / Hematologic Neoplasms Type of study: Diagnostic_studies Limits: Female / Humans Language: En Journal: Journal of Breast Cancer Year: 2019 Document type: Article

Fulltext

Add to My VHL

XML

Search on Google